197 related articles for article (PubMed ID: 10489041)
1. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia.
Chang L; Ernst T; Leonido-Yee M; Witt M; Speck O; Walot I; Miller EN
Neurology; 1999 Sep; 53(4):782-9. PubMed ID: 10489041
[TBL] [Abstract][Full Text] [Related]
2. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
3. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex.
Chang L; Ernst T; Leonido-Yee M; Walot I; Singer E
Neurology; 1999 Jan; 52(1):100-8. PubMed ID: 9921855
[TBL] [Abstract][Full Text] [Related]
4. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV - 1H MRS evaluation.
Tarasów E; Wiercińska-Drapało A; Jaroszewicz J; Orzechowska-Bobkiewicz A; Dzienis W; Prokopowicz D; Walecki J
Med Sci Monit; 2004 Jun; 10 Suppl 3():101-6. PubMed ID: 16538209
[TBL] [Abstract][Full Text] [Related]
6. Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.
Chang L; Ernst T; Witt MD; Ames N; Gaiefsky M; Miller E
Neuroimage; 2002 Nov; 17(3):1638-48. PubMed ID: 12414302
[TBL] [Abstract][Full Text] [Related]
7. A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis.
Lee PL; Yiannoutsos CT; Ernst T; Chang L; Marra CM; Jarvik JG; Richards TL; Kwok EW; Kolson DL; Simpson D; Tang CY; Schifitto G; Ketonen LM; Meyerhoff DJ; Lenkinski RE; Gonzalez RG; Navia BA;
J Magn Reson Imaging; 2003 Jun; 17(6):625-33. PubMed ID: 12766890
[TBL] [Abstract][Full Text] [Related]
8. Changes in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: A coregistered (1)H MRS and SPECT study.
Ernst T; Itti E; Itti L; Chang L
J Magn Reson Imaging; 2000 Dec; 12(6):859-65. PubMed ID: 11105023
[TBL] [Abstract][Full Text] [Related]
9. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.
Harezlak J; Buchthal S; Taylor M; Schifitto G; Zhong J; Daar E; Alger J; Singer E; Campbell T; Yiannoutsos C; Cohen R; Navia B;
AIDS; 2011 Mar; 25(5):625-33. PubMed ID: 21297425
[TBL] [Abstract][Full Text] [Related]
10. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
[TBL] [Abstract][Full Text] [Related]
11. A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS.
Fuller RA; Westmoreland SV; Ratai E; Greco JB; Kim JP; Lentz MR; He J; Sehgal PK; Masliah E; Halpern E; Lackner AA; González RG
BMC Neurosci; 2004 Mar; 5():10. PubMed ID: 15070430
[TBL] [Abstract][Full Text] [Related]
12. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
Gongvatana A; Harezlak J; Buchthal S; Daar E; Schifitto G; Campbell T; Taylor M; Singer E; Algers J; Zhong J; Brown M; McMahon D; So YT; Mi D; Heaton R; Robertson K; Yiannoutsos C; Cohen RA; Navia B;
J Neurovirol; 2013 Jun; 19(3):209-18. PubMed ID: 23613008
[TBL] [Abstract][Full Text] [Related]
13. Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.
Harezlak J; Cohen R; Gongvatana A; Taylor M; Buchthal S; Schifitto G; Zhong J; Daar ES; Alger JR; Brown M; Singer EJ; Campbell TB; McMahon D; So YT; Yiannoutsos CT; Navia BA;
J Neurovirol; 2014 Jun; 20(3):294-303. PubMed ID: 24696364
[TBL] [Abstract][Full Text] [Related]
14. Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury.
Yiannoutsos CT; Nakas CT; Navia BA;
Neuroimage; 2008 Mar; 40(1):248-55. PubMed ID: 18191586
[TBL] [Abstract][Full Text] [Related]
15. Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART.
Chang L; Ernst T; Witt MD; Ames N; Walot I; Jovicich J; DeSilva M; Trivedi N; Speck O; Miller EN
Antivir Ther; 2003 Feb; 8(1):17-26. PubMed ID: 12713060
[TBL] [Abstract][Full Text] [Related]
16. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times.
Laubenberger J; Häussinger D; Bayer S; Thielemann S; Schneider B; Mundinger A; Hennig J; Langer M
Radiology; 1996 Jun; 199(3):805-10. PubMed ID: 8638009
[TBL] [Abstract][Full Text] [Related]
17. Increased glial metabolites predict increased working memory network activation in HIV brain injury.
Ernst T; Chang L; Arnold S
Neuroimage; 2003 Aug; 19(4):1686-93. PubMed ID: 12948723
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.
Chang L; Ernst T; St Hillaire C; Conant K
Antivir Ther; 2004 Jun; 9(3):431-40. PubMed ID: 15259906
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
Chang L; Ernst T; Speck O; Grob CS
Am J Psychiatry; 2005 Feb; 162(2):361-9. PubMed ID: 15677602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
